Marvisi, Chiara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.303
NA - Nord America 2.214
EU - Europa 1.425
SA - Sud America 322
AF - Africa 41
OC - Oceania 12
Totale 6.317
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.171
CN - Cina 873
SG - Singapore 733
IT - Italia 461
HK - Hong Kong 293
BR - Brasile 276
DE - Germania 207
GB - Regno Unito 204
VN - Vietnam 143
RU - Federazione Russa 116
SE - Svezia 99
KR - Corea 98
FI - Finlandia 97
NL - Olanda 43
FR - Francia 40
ID - Indonesia 38
IE - Irlanda 35
AT - Austria 28
IN - India 23
LT - Lituania 21
CA - Canada 20
AR - Argentina 18
BD - Bangladesh 18
MX - Messico 18
BG - Bulgaria 17
TR - Turchia 17
JP - Giappone 16
MA - Marocco 15
AU - Australia 11
UA - Ucraina 11
IQ - Iraq 10
ZA - Sudafrica 9
ES - Italia 8
PL - Polonia 8
CL - Cile 7
IL - Israele 6
PT - Portogallo 6
UZ - Uzbekistan 6
AZ - Azerbaigian 5
CO - Colombia 5
CZ - Repubblica Ceca 5
EC - Ecuador 5
PE - Perù 5
PK - Pakistan 5
SA - Arabia Saudita 5
AE - Emirati Arabi Uniti 4
DZ - Algeria 4
GR - Grecia 4
KE - Kenya 4
BE - Belgio 3
VE - Venezuela 3
AL - Albania 2
CH - Svizzera 2
EG - Egitto 2
KG - Kirghizistan 2
LB - Libano 2
LV - Lettonia 2
PY - Paraguay 2
TH - Thailandia 2
TN - Tunisia 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BJ - Benin 1
BY - Bielorussia 1
BZ - Belize 1
IM - Isola di Man 1
KY - Cayman, isole 1
LI - Liechtenstein 1
MU - Mauritius 1
MW - Malawi 1
NG - Nigeria 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PH - Filippine 1
RO - Romania 1
RS - Serbia 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UY - Uruguay 1
Totale 6.317
Salva come PNG Salva come JPEG
Città #
Santa Clara 659
Hefei 501
Singapore 490
Hong Kong 291
Ashburn 243
London 132
Munich 128
Chandler 101
Seoul 96
Beijing 86
Fairfield 81
Helsinki 76
Los Angeles 64
Nyköping 64
Milan 58
Dallas 53
Ho Chi Minh City 49
Moscow 49
The Dalles 48
New York 42
Chicago 41
Dublin 35
Hanoi 34
Jakarta 32
Seattle 30
Bologna 29
Kent 28
Buffalo 27
Cambridge 26
Shanghai 26
São Paulo 26
Houston 25
Nuremberg 24
Wilmington 24
San Diego 23
Woodbridge 23
Rome 22
Lauterbourg 18
Salt Lake City 18
Portsmouth 17
Redondo Beach 17
Princeton 15
Council Bluffs 14
Frankfurt am Main 14
Rio de Janeiro 14
Bremen 13
Modena 13
Amsterdam 12
Atlanta 12
Florence 12
Haiphong 12
Vienna 12
Sofia 11
Boardman 10
Reggio Emilia 10
Tampa 10
Ankara 9
Brooklyn 9
Denver 9
Lappeenranta 9
Melbourne 9
Tokyo 9
Turku 9
Ann Arbor 8
Des Moines 8
Elk Grove Village 8
Padova 8
Warsaw 8
Casablanca 7
Columbus 7
Lancaster 7
Manchester 7
San Francisco 7
Boston 6
Brasília 6
Brescia 6
Campinas 6
Curitiba 6
Dearborn 6
Düsseldorf 6
Mexico City 6
Montreal 6
Parma 6
Santiago 6
Stockholm 6
Tashkent 6
Thái Bình 6
Trieste 6
Verona 6
Baku 5
Caivano 5
Cremona 5
Dulles 5
Falls Church 5
Guangzhou 5
Hillsboro 5
Naples 5
Palermo 5
Porto Alegre 5
Reston 5
Totale 4.329
Salva come PNG Salva come JPEG
Nome #
Ultrasound Examination of Common Carotid Adventitial Thickness Can Differentiate Takayasu Arteritis and Large Vessel Giant Cell Arteritis 261
VEXAS Syndrome: A Case Series From a Single-Center Cohort of Italian Patients With Vasculitis 254
EULAR guidelines on ANCA-associated vasculitis in the real life 229
Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis (EGPA): a European multicenter observational study 171
Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status 166
Chronic periaortitis presenting with isolated pulmonary artery involvement: description of two cases 161
New perspectives in eosinophilic granulomatosis with polyangiitis (EGPA): report of the first meeting of the European EGPA Study Group 158
Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis: results from the observational GCAGE study on a large cohort of 1004 patients 153
Management of Systemic Sclerosis Patients in the COVID-19 Era: The Experience of an Expert Specialist Reference Center 152
Effectiveness and safety of a 26-week taper regimen of glucocorticoid in GCA patients: Results from a prospective cohort study 142
EVALUATION OF INTERNAL CONSISTENCY, FEASIBILITY, AND RELIABILITY OF THE ITALIAN VERSION OF ANCA-ASSOCIATED VASCULITIS PATIENT-REPORTED OUTCOME (AAV-PRO_ITA) QUESTIONNAIRE: PRELIMINARY RESULTS FROM A MULTICENTER STUDY ON A LARGE COHORT OF ITALIAN PATIENTS 141
Effectiveness of Infliximab and Interferon Alpha-2a for the Treatment of Behçet’s Uveitis: Customizing Therapy according to the Clinical Features 137
Identification of two autoantigens recognised by circulating autoantibodies as potential biomarkers for diagnosing giant cell arteritis 131
Vessel inflammation and morphological changes in patients with large vessel vasculitis: A retrospective study 129
The management of large vessel vasculitides 127
Management of pregnancy in autoimmune rheumatic diseases: maternal disease course, gestational and neonatal outcomes and use of medications in the prospectiveItalian P-RHEUM.it study 126
Tofacitinib for the treatment of refractory Takayasu's arteritis: description of 2 cases 122
Incidence and prevalence of large vessel vasculitis (giant cell arteritis and Takayasu arteritis) in northern Italy: A population-based study 122
117. PREDICTION OF LONG-TERM EVOLUTIONARY PROFILES IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (CHURG– STRAUSS) BASED ON BASELINE AND FOLLOW-UP CHARACTERISTICS 119
EFFICACY OF EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS TREATMENTS ACCORDING TO THE TYPE OF MANIFESTATIONS BASED ON ANALYSIS OF 636 PATIENTS 115
Effects in soluble immune checkpoints induced by Tocilizumab monotherapy after ultra-short-term glucocorticoids in large vessel – giant cell arteritis patients 113
Prevalence and distribution of vascular calcifications at CT scan in patients with and without large vessel vasculitis: A matched cross-sectional study 110
354. EFFICACY OF EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS TREATMENTS ACCORDING TO THE TYPE OF MANIFESTATIONS BASED ON ANALYSIS OF 636 PATIENTS 110
Treatment of giant cell arteritis with ultra-short glucocorticoids and tocilizumab: results from the extension of the TOPAZIO study 109
C-reactive protein gene polymorphisms influence susceptibility and outcomes of biopsy-proven giant cell arteritis in Italian patients 108
Risk of acute arterial and venous thromboembolic events in eosinophilic granulomatosis with polyangiitis (Churg–Strauss syndrome) 105
Clinical and Prognostic Significance of Serum IgG4 in Chronic Periaortitis. An Analysis of 113 Patients 104
Elevated NET, Calprotectin, and Neopterin Levels Discriminate between Disease Activity in COVID-19, as Evidenced by Need for Hospitalization among Patients in Northern Italy 103
Development of the Takayasu Arteritis Integrated Disease Activity Index 102
Significance of PR3-ANCA positivity in eosinophilic granulomatosis with polyangiitis (Churg-Strauss) 102
What to Know About Biopsy Sampling and Pathology in Vasculitis? 101
The role of PET/CT in disease activity assessment in patients with large vessel vasculitis 99
Eosinophilic giant cell arteritis: A different subset of disease? 98
A large-scale genetic analysis reveals an autoimmune origin of idiopathic retroperitoneal fibrosis 96
Trattamento con Tocilizumab in monoterapia dopo trattamento con glucocorticoidi per breve periodo in pazienti con arterite a cellule giganti con coinvolgimento dei grandi vasi: effetti sui checkpoint immunitari solubili 95
Pros and cons of TNF inhibitors and tocilizumab in the treatment of large-vessel vasculitis 95
Validation of the Italian version of the ANCA-associated vasculitis patient-reported outcome (AAV-PRO) questionnaire 93
The Role of PET in the Diagnosis and Disease Activity Assessment in Large Vessel Vasculitis 92
Treatment of giant cell arteritis with ultra-short glucocorticoids and tocilizumab: the role of imaging in a prospective observational study 91
Senescent cells in giant cell arteritis display an inflammatory phenotype participating in tissue injury via IL-6-dependent pathways 91
Steroid-sparing agents in polymyalgia rheumatica: how will they fit into the treatment paradigm? 90
The role of sacro-iliac joint magnetic resonance imaging in the diagnosis of axial spondyloarthritis: focus on differential diagnosis in women 88
Vasculitis, fibromuscular dysplasia or hereditary aneurysms? 88
Aortitis and periaortitis: The puzzling spectrum of inflammatory aortic diseases 86
Evidence-Based Guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis 85
Reply 81
Comment on: Treatment of giant cell arteritis with ultra-short glucocorticoids and tocilizumab: the role of imaging in a prospective observational study. Reply 81
Takayasu arteritis and large-vessel giant cell arteritis in Italian population. Comprehensive analysis from a single institutional cohort of 184 cases 80
Comparing treatment options for large vessel vasculitis 77
Reply to Comment on: Vasculitis, fibromuscular dysplasia or hereditary aneurysms? by Marvisi et al 75
Systemic vasculitis: one year in review 2024 74
PREDICTION OF LONG-TERM EVOLUTIONARY PROFILES IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (CHURG-STRAUSS) BASED ON BASELINE AND FOLLOW-UP CHARACTERISTICS 71
Idiopathic retroperitoneal fibrosis and its overlap with IgG4-related disease 63
Manifestations of Skull Base IgG4‐Related Disease: A Multi‐Institutional Study 61
The geographic and clinical clusters of Behçet’s syndrome 55
Hypereosinophilia and eosinophilic arterial aneurysm: not only eosinophilic granulomatosis with polyangiitis 52
Glucocorticoids versus glucocorticoids plus cyclophosphamide in eosinophilic granulomatosis with polyangiitis with poor-prognosis factors 45
Totale 6.385
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.115
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.115
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202154 0 0 0 0 0 6 9 3 8 5 7 16
2021/2022258 12 24 19 8 11 23 10 13 23 19 46 50
2022/2023483 35 47 28 20 69 51 33 52 60 22 38 28
2023/2024499 14 28 13 62 47 59 65 54 17 33 55 52
2024/20252.752 45 22 89 170 518 449 281 89 327 146 334 282
2025/20262.244 415 260 444 523 543 59 0 0 0 0 0 0
Totale 6.385